Overview
Pancreatoblastoma is a rare, aggressive neoplasm primarily affecting children but can occur in adults. It typically arises from the embryonic multipotent progenitor cells of the pancreas and often presents with advanced disease due to delayed diagnosis 1.Diagnosis
Imaging: Abdominal CT or MRI revealing a large pancreatic mass with potential liver metastases 1.
Histopathology: Essential for definitive diagnosis, showing characteristic features like squamoid corpuscles and acinar formation 1.
Tumor Markers: Elevated serum alpha-fetoprotein levels may correlate with disease progression 1.
Fine Needle Aspiration (FNA): Can be nondiagnostic initially; subsequent biopsies may provide definitive diagnosis 1.Management
Surgical Resection: Palliative resection may be indicated for symptom relief in advanced cases 1.
Chemotherapy: Multiple regimens attempted; specific drug classes not detailed, but progression despite treatment is common 1.
Targeted Therapy: No specific targeted therapies mentioned in the abstract 1.Special Populations
Adults: Presentation and management in adults can be challenging due to rarity and aggressive nature 1.Key Recommendations
Definitive diagnosis requires histopathology demonstrating characteristic features of pancreatoblastoma 1 (Evidence: Strong).
Surgical intervention should be considered for palliation in advanced cases to manage symptoms like pain and hemorrhage 1 (Evidence: Moderate).
Aggressive chemotherapy regimens may be necessary, though efficacy remains limited based on current evidence 1 (Evidence: Weak).References
1 Rajpal S, Warren RS, Alexander M, Yeh BM, Grenert JP, Hintzen S et al.. Pancreatoblastoma in an adult: case report and review of the literature. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2006. link